Analyze Diet

Equine renal hemangiosarcoma: clinical presentation, pathologic features, and pSTAT3 expression.

Abstract: Hemangiosarcoma is an uncommon tumor in horses. We characterized 3 cases of equine renal hemangiosarcoma, focusing on clinical and pathologic features, and describe occurrence of the epithelioid variant of hemangiosarcoma in one of these cases. Nuclear expression of phosphorylated STAT3 (pSTAT3) was assessed to analyze potential inappropriate STAT3 activation as a component of tumor pathogenesis. Clinical signs in the 3 horses included insidious weight loss, followed in one case by serosanguineous nasal discharge and terminal epistaxis, and nonspecific signs of abdominal pain. Two of the hemangiosarcomas had a classical histopathologic appearance; in the other, neoplastic cells were polygonal and were arranged in densely packed sheets, resembling the epithelioid variant. Cross-reactivity of a pSTAT3 antibody was established by demonstration of pSTAT3 expression in the epithelium of glabrous skin by immunoblotting and immunohistochemistry. In the epithelioid hemangiosarcoma, ~40% of neoplastic cells exhibited nuclear pSTAT3 expression, but in the other 2 cases, expression was weak and variable in the neoplastic population, although stromal cell pSTAT3 activity was evident in pulmonary metastases in one case.
Publication Date: 2017-12-03 PubMed ID: 29199537PubMed Central: PMC6505882DOI: 10.1177/1040638717745575Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates three instances of a rare tumor in horses known as equine renal hemangiosarcoma, focusing on their clinical and pathological qualities, and the potential role of STAT3 activation in the development of the tumor.

Study Overview

  • The study involved characterizing three cases of equine renal hemangiosarcoma, which is a rare vascular tumor in horses.
  • The aim of the investigation was to gain an understanding of the clinical and pathologic features of the tumor, including the first reported case of the epithelioid variant, a type of hemangiosarcoma.
  • Additionally, the researchers wanted to assess the role of phosphorylated STAT3 (pSTAT3), a protein associated with cell growth and proliferation, in the development of these tumors.

Clinical Presentation

  • The clinical signs in the horses with these tumors manifested as subtle weight loss, with one also experiencing serosanguineous nasal discharge, sudden nosebleed, and non-specific discomfort in the abdomen.

Pathologic Features and pSTAT3 Expression

  • Two of the hemangiosarcomas presented with classical histopathologic appearance whereas the third case had cells arranged in a densely packed sheet, which is characteristic of the epithelioid variant.
  • Antibodies to pSTAT3 were used to assess the expression of pSTAT3 in the tumors. The researchers validated the antibodies by showing that they can bind to pSTAT3 in the skin cells in an experiment with immunoblotting and immunohistochemistry techniques.
  • In the equine with epithelioid hemangiosarcoma, approximately 40% of tumor cells had nuclear pSTAT3 expression, indicating increased STAT3 activity.
  • However, the two other cases had weaker and variable pSTAT3 expression within the neoplastic cells. Despite this, signs of pSTAT3 activity persisted in the stroma cells of pulmonary metastases in one equine.

Implications

  • The findings provide valuable insight into the clinical and pathologic features of equine renal hemangiosarcoma. This information can contribute to the identification and management of this rare horse tumor.
  • The study also suggests a potential role of pSTAT3 in the pathogenesis of equine renal hemangiosarcoma, warranting further explorative research on this signaling protein and its potential as a therapeutic target.

Cite This Article

APA
Hughes K, Scott VHL, Blanck M, Barnett TP, Spanner Kristiansen J, Foote AK. (2017). Equine renal hemangiosarcoma: clinical presentation, pathologic features, and pSTAT3 expression. J Vet Diagn Invest, 30(2), 268-274. https://doi.org/10.1177/1040638717745575

Publication

ISSN: 1943-4936
NlmUniqueID: 9011490
Country: United States
Language: English
Volume: 30
Issue: 2
Pages: 268-274

Researcher Affiliations

Hughes, Katherine
    Scott, Victoria H L
      Blanck, Maximilian
      • 2 Horizon Discovery, Waterbeach, Cambridge, UK.
      Barnett, Timothy P
        Spanner Kristiansen, Jannie
          Foote, Alastair K

            MeSH Terms

            • Animals
            • Biomarkers, Tumor / metabolism
            • Cell Nucleus / pathology
            • Diagnosis, Differential
            • Female
            • Hemangiosarcoma / diagnosis
            • Hemangiosarcoma / metabolism
            • Hemangiosarcoma / veterinary
            • Horse Diseases / diagnosis
            • Horse Diseases / metabolism
            • Horse Diseases / pathology
            • Horses
            • Immunohistochemistry / veterinary
            • Kidney Neoplasms / diagnosis
            • Kidney Neoplasms / metabolism
            • Kidney Neoplasms / veterinary
            • Male
            • STAT3 Transcription Factor / metabolism

            Conflict of Interest Statement

            The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

            References

            This article includes 25 references
            1. Arenas-Gamboa AM, Mansell J. Epithelioid haemangiosarcoma in the ocular tissue of horses.. J Comp Pathol 2011 May;144(4):328-33.
              pubmed: 21251669doi: 10.1016/j.jcpa.2010.10.011google scholar: lookup
            2. Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.. Clin Cancer Res 2002 Apr;8(4):945-54.
              pubmed: 11948098
            3. Chapman RS, Lourenco PC, Tonner E, Flint DJ, Selbert S, Takeda K, Akira S, Clarke AR, Watson CJ. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3.. Genes Dev 1999 Oct 1;13(19):2604-16.
              pmc: PMC317074pubmed: 10521404doi: 10.1101/gad.13.19.2604google scholar: lookup
            4. Collins MB, Hodgson DR, Hutchins DR, McConaghy FF. Haemangiosarcoma in the horse: three cases.. Aust Vet J 1994 Sep;71(9):296-8.
            5. Dawson DR. Epithelioid variant of haemangiosarcoma in a gelding.. Equine Vet Educ 2009;21:519–524.
            6. East LM. Weight loss in the horse: a focus on abdominal neoplasia.. Equine Vet Educ 1999;11:174–178.
            7. Finbloom DS, Larner AC. Regulation of the Jak/STAT signalling pathway.. Cell Signal 1995 Nov;7(8):739-45.
              pubmed: 8593242doi: 10.1016/0898-6568(95)02004-7google scholar: lookup
            8. Geelen SN, Sloet van Oldruitenborgh-Oosterbaan MM. [A pony with a metastasized hemangiosarcoma].. Tijdschr Diergeneeskd 1996 Oct 1;121(19):544-6.
              pubmed: 8966699
            9. Gross TLI. Vascular tumors.. In: Skin Diseases of the Dog and Cat: Clinical and Histopathologic Diagnosis. 2nd ed. Oxford, UK: Blackwell Science, 2005:749–753.
            10. Gumber S, Baia P, Wakamatsu N. Vulvar epithelioid hemangiosarcoma with solar elastosis in a mare.. J Vet Diagn Invest 2011 Sep;23(5):1033-6.
              pubmed: 21908370doi: 10.1177/1040638711407302google scholar: lookup
            11. Hughes K, Blanck M, Pensa S, Watson CJ. Stat3 modulates chloride channel accessory protein expression in normal and neoplastic mammary tissue.. Cell Death Dis 2016 Oct 6;7(10):e2398.
              pmc: PMC5133972pubmed: 27711075doi: 10.1038/cddis.2016.302google scholar: lookup
            12. Hughes K, Scase TJ, Foote AK. Estrogen Receptor and Signal Transducer and Activator of Transcription 3 Expression in Equine Mammary Tumors.. Vet Pathol 2015 Jul;52(4):631-4.
              pubmed: 25421423doi: 10.1177/0300985814559400google scholar: lookup
            13. Iannaci G, Crispino M, Cifarelli P, Montella M, Panarese I, Ronchi A, Russo R, Tremiterra G, Luise R, Sapere P. Epithelioid angiosarcoma arising in schwannoma of the kidney: report of the first case and review of the literature.. World J Surg Oncol 2016 Feb 3;14(1):29.
              pmc: PMC4739400pubmed: 26842370doi: 10.1186/s12957-016-0789-5google scholar: lookup
            14. Johnson JE, Beech J, Saik JE. Disseminated hemangiosarcoma in a horse.. J Am Vet Med Assoc 1988 Dec 1;193(11):1429-31.
              pubmed: 3209458
            15. Khaled WT, Read EK, Nicholson SE, Baxter FO, Brennan AJ, Came PJ, Sprigg N, McKenzie AN, Watson CJ. The IL-4/IL-13/Stat6 signalling pathway promotes luminal mammary epithelial cell development.. Development 2007 Aug;134(15):2739-50.
              pubmed: 17611223doi: 10.1242/dev.003194google scholar: lookup
            16. Kiupel M, Frank N, Stevenson GW, Siems J, Snyder PW. Intrapelvic hemangiosarcoma in a horse.. J Vet Diagn Invest 2000 Jan;12(1):91-5.
              pubmed: 10690788doi: 10.1177/104063870001200121google scholar: lookup
            17. Nishio H, Matsui K, Tsuji H, Tamura A, Suzuki K. Immunolocalisation of the janus kinases (JAK)--signal transducers and activators of transcription (STAT) pathway in human epidermis.. J Anat 2001 May;198(Pt 5):581-9.
            18. Omiyale AO. Clinicopathological features of primary angiosarcoma of the kidney: a review of 62 cases.. Transl Androl Urol 2015 Aug;4(4):464-73.
            19. Petterino C, Rossetti E, Drigo M. Immunodetection of the signal transducer and activator of transcription-3 in canine haemangioma and haemangiosarcoma.. Res Vet Sci 2006 Apr;80(2):186-8.
              pubmed: 16098550doi: 10.1016/j.rvsc.2005.05.009google scholar: lookup
            20. Southwood LL, Schott HC 2nd, Henry CJ, Kennedy FA, Hines MT, Geor RJ, Hassel DM. Disseminated hemangiosarcoma in the horse: 35 cases.. J Vet Intern Med 2000 Jan-Feb;14(1):105-9.
            21. Summers BA. Mimicry in neoplasia: when tumours don’t play fair.. Equine Vet Educ 2009;21:525–526.
            22. Taintor J. Haemangiosarcoma in the horse.. Equine Vet Educ 2014;26:499–503.
            23. Tan RM, Stern AW, Schliewert EC. Pathology in practice. Hemangiosarcoma.. J Am Vet Med Assoc 2014 Apr 15;244(8):909-11.
              pubmed: 24697766doi: 10.2460/javma.244.8.909google scholar: lookup
            24. Warren AL, Summers BA. Epithelioid variant of hemangioma and hemangiosarcoma in the dog, horse, and cow.. Vet Pathol 2007 Jan;44(1):15-24.
              pubmed: 17197620doi: 10.1354/vp.44-1-15google scholar: lookup
            25. Yuan J, Zhang F, Niu R. Multiple regulation pathways and pivotal biological functions of STAT3 in cancer.. Sci Rep 2015 Dec 3;5:17663.
              pmc: PMC4668392pubmed: 26631279doi: 10.1038/srep17663google scholar: lookup

            Citations

            This article has been cited 1 times.
            1. Shih CH, Chang YC, Lai YC, Chiou HY. Investigating the role of signal transducer and activator of transcription 3 in feline injection site sarcoma. BMC Vet Res 2022 Jul 14;18(1):276.
              doi: 10.1186/s12917-022-03352-ypubmed: 35836213google scholar: lookup